Please login to the form below

Not currently logged in
Email:
Password:

Paxlovid

This page shows the latest Paxlovid news and features for those working in and with pharma, biotech and healthcare.

NICE publishes final draft guidance recommending three COVID-19 treatments

NICE publishes final draft guidance recommending three COVID-19 treatments

The agency’s latest guidance recommends the use of Pfizer’s Paxlovid (tirmatrelvir plus ritonavir), GSK’s Xevudy (sotrovimab) and Roche’s RoActemra (tocilizumab). ... Paxlovid has been recommended for adults who do not need supplemental oxygen

Latest news

More from news
Approximately 10 fully matching, plus 10 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...